Recombinant human coagulation factor VIIa-Fc fusion protein(Jiangsu Gensciences)

重组人凝血因子VIIa-Fc融合蛋白（江苏晟斯）

Report date: 2024/04/02 14:13:33

Base Information

Drug NameRecombinant human coagulation factor VIIa-Fc fusion protein(Jiangsu Gensciences)
Drug Alias NameSS109SS-109
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulants
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia BHemophilia AFactor VII Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Gensciences lnc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu Gensciences lnc
Inactive CompaniesN/A
Active IndicationsHemophilia BHemophilia AFactor VII Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A